Webcam Delivery of the Camperdown Program for Adolescents Who Stutter: A Phase II Trial

被引:38
|
作者
Carey, Brenda [1 ]
O'Brian, Sue [1 ]
Lowe, Robyn [1 ]
Onslow, Mark [1 ]
机构
[1] Univ Sydney, Australian Stuttering Res Ctr, Sydney, NSW 2006, Australia
关键词
stuttering; adolescents; Camperdown Program; telehealth; LONG-TERM; CLINICAL-TRIAL; SPEECH; ADULTS; SEVERITY; CHILDREN; RELIABILITY; STEREOTYPES; ATTITUDES; THERAPY;
D O I
10.1044/2014_LSHSS-13-0067
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Purpose: This Phase II clinical trial examined stuttering adolescents' responsiveness to the Webcam-delivered Camperdown Program. Method: Sixteen adolescents were treated by Webcam with no clinic attendance. Primary outcome was percentage of syllables stuttered (%SS). Secondary outcomes were number of sessions, weeks and hours to maintenance, self-reported stuttering severity, speech satisfaction, speech naturalness, self-reported anxiety, self-reported situation avoidance, self-reported impact of stuttering, and satisfaction with Webcam treatment delivery. Data were collected before treatment and up to 12 months after entry into maintenance. Results: Fourteen participants completed the treatment. Group mean stuttering frequency was 6.1 %SS (range, 0.7-14.7) pretreatment and 2.8 %SS (range, 0-12.2) 12 months after entry into maintenance, with half the participants stuttering at 1.2 %SS or lower at this time. Treatment was completed in a mean of 25 sessions (15.5 hr). Self-reported stuttering severity ratings, self-reported stuttering impact, and speech satisfaction scores supported %SS outcomes. Minimal anxiety was evident either pre- or post-treatment. Individual responsiveness to the treatment varied, with half the participants showing little reduction in avoidance of speech situations. Conclusions: The Webcam service delivery model was appealing to participants, although it was efficacious and efficient for only half. Suggestions for future stuttering treatment development for adolescents are discussed.
引用
收藏
页码:314 / 324
页数:11
相关论文
共 50 条
  • [21] Family-based treatment with metacognitive therapy for adolescents with anorexia nervosa: findings from a phase II trial
    Beate Østgård
    Gunn Julie D. Nordahl
    Arve Strandheim
    Hans M. Nordahl
    Journal of Eating Disorders, 13 (1)
  • [22] Gastroenteritis aggressive versus slow treatment for rehydration (GASTRO): a phase II rehydration trial for severe dehydration: WHO plan C versus slow rehydration
    Houston, Kirsty A.
    Gibb, Jack
    Olupot-Olupot, Peter
    Obonyo, Nchafatso
    Mpoya, Ayub
    Nakuya, Margaret
    Muhindo, Rita
    Uyoga, Sophie
    Evans, Jennifer A.
    Connon, Roisin
    Gibb, Diana M.
    George, Elizabeth C.
    Maitland, Kathryn
    BMC MEDICINE, 2019, 17 (1)
  • [23] Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation
    Wu, Olivia
    Boyd, Kathleen
    Paul, Jim
    McCartney, Elaine
    Ritchie, Moira
    Mellon, D.
    Kelly, Linda
    Dixon-Hughes, Judith
    Moss, Jon
    BRITISH JOURNAL OF CANCER, 2016, 114 (09) : 979 - 985
  • [24] A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
    Pinto, Jorge A.
    Capparelli, Edmund V.
    Warshaw, Meredith
    Zimmer, Bonnie
    Cressey, Tim R.
    Spector, Stephen A.
    Qin, Min
    Smith, Betsy
    Siberry, George K.
    Mirochnick, Mark
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (02) : e29 - e35
  • [25] Online CBT II: A Phase I Trial of a Standalone, Online CBT Treatment Program for Social Anxiety in Stuttering
    Helgadottir, Fjola Doegg
    Menzies, Ross G.
    Onslow, Mark
    Packman, Ann
    O'Brian, Sue
    BEHAVIOUR CHANGE, 2009, 26 (04) : 254 - 270
  • [26] A Phase II Multicentered, Single-Blind, Randomized, Controlled Trial of the Stroke Self-Management Program
    Cadilhac, Dominique A.
    Hoffmann, Sally
    Kilkenny, Monique
    Lindley, Richard
    Lalor, Erin
    Osborne, Richard H.
    Batterbsy, Malcolm
    STROKE, 2011, 42 (06) : 1673 - 1679
  • [27] A randomized phase II trial of induction chemotherapy followed by cisplatin chronotherapy versus constant rate delivery combined with radiotherapy
    Zhang, P. X.
    Jin, F.
    Li, Z. L.
    Wu, W. L.
    Li, Y. Y.
    Long, J. H.
    Chen, G. Y.
    Chen, X. X.
    Gan, J. Y.
    Gong, X. Y.
    He, Q. Y.
    Bi, T.
    CHRONOBIOLOGY INTERNATIONAL, 2018, 35 (02) : 240 - 248
  • [28] Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Nosbaum, Audrey
    Winthrop, Kevin L.
    Guttman-Yassky, Emma
    Hoffmeister, Karin M.
    Egeberg, Alexander
    Valdez, Hernan
    Zhang, Min
    Farooqui, Saleem A.
    Romero, William
    Thorpe, Andrew J.
    Rojo, Ricardo
    Johnson, Susan
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (05) : 693 - 707
  • [29] Cultural Accommodation of the Strengthening Families Program for Parents and Young Adolescents 10-14: Greek Phase I and II Study
    Kyritsi, Konstantina P.
    Bacopoulou, Flora
    GENEDIS 2020: GENETICS AND NEURODEGENERATIVE DISEASES, 2021, 1339
  • [30] Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy
    Yardley, Denise A.
    Peacock, Nancy
    Daniel, Brooke
    Anz, Betrand
    Molthrop, David C., Jr.
    Shroff, Sonalee K.
    Young, Robyn
    Jankov, Aleksander
    Vander Woude, Amy
    Shastry, Mythili
    Pasek, Johanna
    DeBusk, Laura M.
    Hainsworth, John D.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (03) : 647 - 655